![Robert Tucci](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Tucci
Directeur/Bestuurslid bij Adient Medical, Inc.
Profiel
Robert Tucci is currently a Managing Director at Texas Halo Fund Management LLC, a Board of Director at Adient Medical, Inc., and a Director at Drusolv Therapeutics, Inc. He previously served as a Board of Director at Amigos de las Américas and as Chair & Life Science at The Houston Angel Network.
Tucci received his undergraduate degree from Ursinus College in 1978 and his MBA from A.B.
Freeman School of Business in 1980.
Actieve functies van Robert Tucci
Bedrijven | Functie | Begin |
---|---|---|
Texas Halo Fund Management LLC
![]() Texas Halo Fund Management LLC Investment ManagersFinance Texas Halo Fund Management LLC (Texas Halo Fund) is a venture capital firm founded in 2010 by Andrew Clark and David Steakley. The firm is Headquartered in Houston, Texas. | Private Equity Investor | 07-01-2006 |
Adient Medical, Inc.
![]() Adient Medical, Inc. Medical SpecialtiesHealth Technology Adient Medical, Inc. develops and manufactures absorbable medical devices. It offers an absorbable vascular filter for the prevention of pulmonary embolism. The company was founded in 2012 and is headquartered in Pearland, TX. | Directeur/Bestuurslid | 01-01-2013 |
Drusolv Therapeutics, Inc.
![]() Drusolv Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Drusolv Therapeutics, Inc. is an American clinical-stage drug company that is developing a high-dose statin for early intervention in age-related macular degeneration. The CEO of the company is John G. Edwards. | Private Equity Investor | 01-05-2022 |
Eerdere bekende functies van Robert Tucci
Bedrijven | Functie | Einde |
---|---|---|
The Houston Angel Network
![]() The Houston Angel Network Investment ManagersFinance The Houston Angel Network functions as an alternative investment manager. The private company is based in Houston, TX. | Private Equity Investor | 01-07-2018 |
Amigos de las Américas
![]() Amigos de las Américas Miscellaneous Commercial ServicesCommercial Services Amigos de las Américas provides training and leadership programmes. It offers summer and gap programs for young people ages 13-25. The company was founded by Guy Bevil Jr. in 1965 and is headquartered in Houston, TX. | Directeur/Bestuurslid | 31-12-2013 |
Opleiding van Robert Tucci
Ursinus College | Undergraduate Degree |
A.B. Freeman School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Amigos de las Américas
![]() Amigos de las Américas Miscellaneous Commercial ServicesCommercial Services Amigos de las Américas provides training and leadership programmes. It offers summer and gap programs for young people ages 13-25. The company was founded by Guy Bevil Jr. in 1965 and is headquartered in Houston, TX. | Commercial Services |
Texas Halo Fund Management LLC
![]() Texas Halo Fund Management LLC Investment ManagersFinance Texas Halo Fund Management LLC (Texas Halo Fund) is a venture capital firm founded in 2010 by Andrew Clark and David Steakley. The firm is Headquartered in Houston, Texas. | Finance |
Adient Medical, Inc.
![]() Adient Medical, Inc. Medical SpecialtiesHealth Technology Adient Medical, Inc. develops and manufactures absorbable medical devices. It offers an absorbable vascular filter for the prevention of pulmonary embolism. The company was founded in 2012 and is headquartered in Pearland, TX. | Health Technology |
The Houston Angel Network
![]() The Houston Angel Network Investment ManagersFinance The Houston Angel Network functions as an alternative investment manager. The private company is based in Houston, TX. | Finance |
Drusolv Therapeutics, Inc.
![]() Drusolv Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Drusolv Therapeutics, Inc. is an American clinical-stage drug company that is developing a high-dose statin for early intervention in age-related macular degeneration. The CEO of the company is John G. Edwards. | Commercial Services |